当前位置:首页 - 行情中心 - 华海药业(600521) - 财务分析

华海药业

(600521)

  

流通市值:351.94亿  总市值:361.89亿
流通股本:14.56亿   总股本:14.97亿

华海药业(600521)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润4.05亿元,每股收益0.28元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益1000513.15万元,未分配利润596486.85万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产2126589.85万元,负债1126076.70万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入4,516,353,788.972,368,563,881.429,547,425,412.47,247,654,219.7
营业总成本4,001,688,219.952,002,446,656.27,978,739,192.175,940,775,917.63
其他经营收益
营业利润541,255,245.22376,768,523.141,470,788,599.091,316,952,527.66
利润总额542,860,973.47375,012,300.241,463,608,474.951,311,263,170.14
净利润405,158,861.54296,039,678.321,107,463,116.831,037,247,794.71
每股收益
其他综合收益2,468,726.33739,654.29-110,875.97-6,120,263.49
综合收益总额407,627,587.87296,779,332.611,107,352,240.861,031,127,531.22
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计8,899,110,228.739,462,382,014.628,483,148,001.257,980,130,228.56
非流动资产:
非流动资产合计12,366,788,240.7512,035,007,077.1711,778,206,968.6711,575,059,548.77
资产总计21,265,898,469.4821,497,389,091.7920,261,354,969.9219,555,189,777.33
流动负债:
流动负债合计5,699,401,455.325,845,558,391.655,975,663,102.395,683,769,186.07
非流动负债:
非流动负债合计5,561,365,499.735,749,196,460.155,265,657,716.624,916,472,122.58
负债合计11,260,766,955.0511,594,754,851.811,241,320,819.0110,600,241,308.65
所有者权益(或股东权益):
归属于母公司股东权益合计9,910,300,224.439,779,249,594.438,897,779,286.948,792,525,623.87
股东权益合计10,005,131,514.439,902,634,239.999,020,034,150.918,954,948,468.68
负债和股东权益合计21,265,898,469.4821,497,389,091.7920,261,354,969.9219,555,189,777.33
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计4,598,112,323.592,339,998,592.029,567,245,725.877,606,205,640.3
经营活动现金流出小计4,228,474,611.062,144,890,933.167,394,581,802.065,728,821,853.17
经营活动产生的现金流量净额369,637,712.53195,107,658.862,172,663,923.811,877,383,787.13
投资活动产生的现金流量:
投资活动现金流入小计76,504,440.7820,067,013.731,710,230.099,048,365.03
投资活动现金流出小计875,424,761.71452,226,040.731,951,986,252.31,194,336,249.1
投资活动产生的现金流量净额-798,920,320.93-432,159,027.03-1,920,276,022.21-1,185,287,884.07
筹资活动产生的现金流量:
筹资活动现金流入小计2,144,748,145.881,737,502,068.976,201,877,6104,012,608,010
筹资活动现金流出小计1,615,705,090.56781,873,469.886,334,789,676.274,618,819,743.26
筹资活动产生的现金流量净额529,043,055.32955,628,599.09-132,912,066.27-606,211,733.26
汇率变动对现金及现金等价物的影响7,777,954.175,149,356.7451,158,021.95669,731.69
现金及现金等价物净增加额107,538,401.09723,726,587.66170,633,857.2886,553,901.49
期末现金及现金等价物余额1,585,138,621.12,201,326,807.671,477,600,220.011,393,520,264.22
补充资料:
现金及现金等价物的净增加额107,538,401.09-170,633,857.28-
最新报告期:2025-08-27
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中金公司张琎,吴婉桦0.810.94--2025-08-27
TOP↑